Medical Oncologist
When treatment stops working
Your Scan Shows Progression: — What Comes Next
Hearing that your scan shows progression is one of the hardest moments in a cancer journey. It means this treatment has stopped working — not that all treatment has stopped working. Understanding why it happened and what your team can do next is where most people want to start.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- This line has stopped, not all lines — Progression means the current drug or regimen is no longer controlling the cancer. It does not mean treatment is over.
- Resistance is biological, not a failure — Cancer cells mutate over time. Some develop ways to survive the treatment that was working. This is a known process your oncologist has planned for.
- Next-line options exist — Most treatment protocols anticipate progression. Your team will discuss which options apply to your specific cancer type and condition.
- You have time to ask questions — In most cases, a few days to gather your thoughts and ask what you need to know will not change the outcome.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A progression scan means the current treatment has stopped working — not that treatment overall has failed. Cancer develops resistance through changes in its own cells, and there are usually next-line options to consider. Your oncologist will explain what those options are for your specific situation and what each one aims to achieve.
What does a progression scan actually mean?
A progression scan shows that the cancer has grown, spread to new areas, or returned after a period of control. It means the treatment you are on has stopped doing what it was supposed to do.
It does not mean the cancer has become untreatable. It means this particular treatment line is no longer the right one, and the conversation now moves to what comes next.
The hardest part of this news is often the shock of it. Many people describe feeling that the ground has shifted under them. That reaction is completely normal, and it does not mean you are not coping.
What should I do in the first few days after getting this news?
- Write down the questions you most want answered before your next appointment.
- Ask your team for the scan report in writing if you would like to read it yourself.
- Bring someone you trust to the next appointment to help you remember what was said.
- Ask when the next appointment will be and what will be decided at it — knowing the timeline helps.
- Hold off on researching treatment options until you know what your oncologist is actually considering.
- Tell your team if you are struggling emotionally — oncology social workers and counsellors are part of the care team.
Why does cancer stop responding to treatment?
Cancer cells are not identical to each other, even within the same tumour. Some carry mutations that make them slightly resistant to the drug being used. When treatment kills the sensitive cells, the resistant ones survive and multiply.
Over time, treatment selects for the very cells it cannot kill. This is why a drug that worked well initially can become less effective — without anything going wrong in how it was given or how you responded to it.
This process is well understood. Oncologists plan for it by designing treatment sequences in advance. The existence of a second or third line of treatment reflects the fact that resistance was anticipated from the start.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What next-line options will my oncologist consider?
The options depend on your cancer type, how much treatment you have had before, your current fitness, and what your biomarker profile shows. There is no single answer that applies across cancer types.
In general, next-line options include switching to a different chemotherapy regimen, moving to a targeted therapy if a relevant mutation is identified, adding or starting immunotherapy, enrolling in a clinical trial, or in some cases focusing treatment on a specific site with radiation.
Your oncologist will also consider what the goal of next treatment is — whether it aims to control the cancer for as long as possible, reduce a specific symptom, or maintain quality of life. Asking about the goal is a reasonable and important question.
How does the decision about next treatment get made?
Review the scan findings
Your oncologist confirms what the scan shows and where the cancer has grown or spread.
Check what treatment has already been given
The full treatment history determines which drugs are still available and which have already been used.
Reassess your fitness and current health
A performance status assessment helps determine which regimens are appropriate given how you are feeling now.
Revisit the biomarker profile
If earlier testing did not cover a marker that is now relevant, a repeat biopsy or liquid biopsy may be ordered before a decision is made.
Discuss options and decide together
Your oncologist will present the options with what each one aims to achieve. You decide together — including the option of not starting further active treatment.
Did you know?
Most oncology treatment plans are designed as sequences, not single lines. Progression on first-line treatment moves the plan to the next stage — one that was considered before your first dose was given.
The existence of a second line is not improvisation. It is the plan working as designed.
Source: NCCN Clinical Practice Guidelines in Oncology
Explore 39 more Monitoring, Resistance & Long-Term Response topics
Resistance, Progression & Next Lines
- Being Told 'There Are No More Options': Is That Really True?
- Brain Metastases on Targeted Therapy: Does Your Drug Reach the Brain?
- Can You Continue the Same Drug After Progression?
- Combination Therapy to Overcome Resistance
- Do You Need Another Biopsy When the Cancer Progresses?
- Histologic Transformation: When Lung Cancer Changes Type
- How to Emotionally Process a Progression Scan
- Leptomeningeal Disease: Symptoms, Diagnosis and Treatment
- Life After ALK Inhibitor Resistance: Sequencing Your Options
- MET Amplification and Other Bypass Resistance Mechanisms
- Oligoprogression: When Only One or Two Spots Grow
- Primary vs Acquired Resistance: Two Very Different Problems
- Should You Change Hospitals After Progression?
- What Happens After Osimertinib Stops Working?
- What Is Sequencing and Why the Order of Drugs Matters
- Why Does Targeted Therapy Stop Working? The Biology of Resistance
Long-Term Response, Stopping & Survivorship
- Am I Still a Cancer Patient? Identity After Long-Term Response
- Bone Health, Heart Health and Late Effects to Monitor
- Can You Ever Stop Targeted Therapy If the Cancer Is Gone?
- Drug Holidays: Are Planned Breaks Safe?
- Follow-Up Schedule After Stopping Targeted Therapy
- How Long Do You Have to Stay on Targeted Therapy?
- Long-Term Effects of Taking a TKI for 5 or 10 Years
- Restarting Treatment After a Break
- Treatment-Free Remission in CML: Who Can Stop Their TKI?
- Your Survivorship Care Plan: What Should Be In It
Monitoring, Scans & Response Assessment
- Are Tumour Markers Reliable on Targeted Therapy?
- Complete Response, Partial Response, Stable Disease: What Each Means
- Do I Need Regular Brain MRIs on Targeted Therapy?
- How Doctors Measure Whether Targeted Therapy Is Working
- How Often Will I Need Scans on Targeted Therapy?
- How to Read a CT or PET Scan Report Without Panicking
- Is 'Stable Disease' Good News or Bad News?
- Scanxiety: How to Get Through the Wait for Scan Results
- Tumour Flare and Pseudoprogression: When Growth Isn't Really Growth
- Understanding PFS, OS and Median Survival Without Losing Hope
- What Happens at a Follow-Up Visit: A Walk-Through
- Which Blood Tests Are Repeated Every Month and Why
- ctDNA Monitoring: Can a Blood Test Predict Progression Early?
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Does progression mean the cancer is now untreatable?
No. Progression means the current treatment line is no longer working, not that all treatment options are exhausted. Most cancer types have multiple lines of treatment, and your oncologist will discuss which ones apply to your situation. The number of options available depends on your cancer type, how much treatment you have had, and your current health. Ask directly what lines remain and what each one is intended to achieve.
How quickly do we need to decide on the next treatment?
In most cases, a few days to absorb the news, gather your questions, and have a proper conversation will not change the outcome. Your oncologist will tell you if there is a clinical reason to move faster — for example, if a symptom needs urgent attention or if a trial has an enrolment deadline. If urgency has not been mentioned, it is reasonable to ask: is there a medical reason to decide this week, or do we have time to think it through?
Should we get a second opinion after a progression scan?
Yes, if it would help you feel confident in the plan. A second opinion on next-line treatment is routine in oncology, and most oncologists expect and support it. It is most useful when the options are genuinely complex — for example, when a clinical trial is being considered, or when the recommendation is to stop active treatment. Ask your current team for the scan images and the full treatment summary so the second opinion has everything it needs.
What is a clinical trial and should I consider one after progression?
A clinical trial tests a treatment or combination that is not yet standard. After progression is one of the most common points at which trials become available, because many are specifically designed for patients whose cancer has stopped responding to standard treatment. Whether one is right for you depends on the trial's eligibility criteria, what it is testing, and where it is being conducted. Ask your oncologist whether a trial fits your current situation and what participating would involve in practical terms.
What if I am not fit enough to tolerate more treatment?
Fitness for treatment is assessed at each decision point, not set once. If your current health means that standard next-line treatment would cause more harm than benefit, your oncologist will say so plainly. The options at that point include lower-intensity regimens, treatment aimed at specific symptoms, or focusing care on comfort and quality of life. None of these is giving up — they are clinical decisions made in your interest, and your team can explain exactly what each one involves.
How do we tell children or elderly parents about the progression?
There is no single right way, and what works depends on age, relationship, and how much the person wants to know. For children, child psychologists and oncology social workers can advise on language that is honest without being frightening. For older relatives, the main question is usually how much detail they want — ask them directly rather than deciding for them. Your oncology team sees this situation regularly and can connect you with a social worker or counsellor who helps with exactly this.